CARE-MS I Follow-up: Alemtuzumab Efficacy, Safety for MS Treatment Maintained for More than 4 Years

Article Information

DOI 
http://dx.doi.org/10.1177/155989771429008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2014 MD Conference Express®

Author Information

  1. Brian Hoyle
  1. Alasdair J. Coles, MD
    1. University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
View Full Text

Article usage

AbstractFullPDF
Apr 2015700
May 2015501
Jun 2015200
Jul 2015111
Aug 2015720
Sep 2015200
Oct 2015233
Total2665

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
CARE-MS I Follow-up: Alemtuzumab Efficacy, Safety for MS Treatment Maintained for More than 4 Years
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Neurology Clinical Trials
Demyelinating Diseases
Neurology Clinical Trials
Neurology
Demyelinating Diseases